IgA Nephropathy trials recruiting in California

Fewer than 3 recruiting trials found.

All IgA Nephropathy trials nationally

Cities in California

Recruiting trials in California

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: Fresno, Orange, San Bernardino, San Francisco